Atai Life Sciences N.V. 13D and 13G filings for IntelGenx Technologies Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-03 4:06 pm Purchase | 2024-04-19 | 13D | IntelGenx Technologies Corp. IGXT | ATAI Life Sciences N.V. ATAI | 263,032,812 65.700% | 5,405,405 (+2.10%) | Filing |
| 2024-03-12 9:30 pm Sale | 2023-09-30 | 13D | IntelGenx Technologies Corp. IGXT | ATAI Life Sciences N.V. ATAI | 257,627,407 65.200% | -51,693 (-0.02%) | Filing |
| 2023-09-06 9:22 pm Purchase | 2023-08-31 | 13D | IntelGenx Technologies Corp. IGXT | ATAI Life Sciences N.V. ATAI | 257,679,100 65.200% | 23,999,100 (+10.27%) | Filing |
| 2021-05-24 4:30 pm Purchase | 2021-05-14 | 13D | IntelGenx Technologies Corp. IGXT | ATAI Life Sciences N.V. ATAI | 233,680,000 67.600% | 233,680,000 (New Position) | Filing |